What you'll receive
Patent attorneys spend hours manually reviewing lengthy applications to extract key claims, technical details, and strategic insights for clients and prosecution decisions. This time-consuming process delays client communications, slows portfolio management, and increases costs for routine IP tasks that require deep document analysis.
Patent attorneys spend hours manually reviewing lengthy applications to extract key claims, technical details, and strategic insights for clients and prosecution decisions. This time-consuming process delays client communications, slows portfolio management, and increases costs for routine IP tasks that require deep document analysis.
CaseMark automatically analyzes patent applications to generate comprehensive, professionally structured summaries in minutes. Extract bibliographic data, independent claims, technical descriptions, and strategic considerations with AI-powered precision, enabling faster client communications and more efficient IP practice management.
This workflow is applicable across multiple practice areas and use cases
Patent application summaries are essential for analyzing patent claims, prior art, and prosecution history during patent infringement litigation and validity challenges.
IP litigators regularly need to review and analyze patent applications to understand claim scope, prosecution estoppel, and to prepare invalidity defenses or infringement arguments.
Patent application summaries streamline IP due diligence in M&A transactions by quickly identifying key patent claims, prosecution status, and portfolio strength.
M&A attorneys must review patent portfolios during due diligence to assess IP asset value, identify risks, and evaluate the target company's competitive advantages.
Patent portfolio analysis is critical during due diligence for technology company investments to assess IP asset value and competitive positioning.
VC and PE firms need to evaluate patent applications and portfolios when conducting IP due diligence on potential investments, particularly in technology and biotech sectors.
Patent application analysis helps pharmaceutical and medical device companies navigate patent exclusivity periods, regulatory exclusivity, and patent linkage requirements.
FDA regulatory attorneys need to analyze patent applications for drug and device approvals, ANDA filings, and patent certification requirements under Hatch-Waxman and BPCIA frameworks.
The summary includes bibliographic data (application number, filing date, inventors, assignee), technical field and background, detailed invention description, independent and dependent claim analysis, drawings overview, prior art distinctions, and strategic considerations for prosecution or licensing. Each summary provides specific citations to relevant sections and claim numbers for easy reference to the full application.
CaseMark examines independent claims to assess breadth of protection and identifies dependent claims with commercial significance. The analysis flags potential issues like means-plus-function language, indefiniteness concerns, enablement questions, and design-around opportunities. This helps attorneys quickly understand the patent's protective scope and anticipate prosecution challenges.
Yes, summaries are formatted professionally for direct inclusion in client memoranda, portfolio reports, and case management systems. The output balances technical accuracy with accessibility for non-specialist audiences, using precise IP terminology while remaining clear and concise. Summaries typically span 1-3 pages and enable clients to understand key aspects within minutes.
CaseMark systematically analyzes the entire patent document including specification, claims, drawings, and abstract to ensure comprehensive extraction. The AI is trained on patent-specific language and structure, maintaining technical accuracy while identifying innovative aspects, claim limitations, and prior art distinctions. All outputs include specific citations allowing attorneys to verify details in the source document.